Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnevist-enhanced MRI in infants and young children (pharmacokinetics, safety, efficacy)
2009-013081-17Phase 3Completed
- Sponsor
- Bayer
- Start
- Aug 2009
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of gadopentetate dimeglumine (2 arms), sponsored by Bayer. Started Aug 2009; status: completed.
02
Drugs
gadopentetate dimeglumine
Beyond the preview
Go deeper on 2009-013081-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013081-17.